The comparative efficacy of SGLT-2 inhibitors and GLP-1 receptor agonists on metabolic benefits in T2DM patients: a systematic review and network meta-analysis
Abstract Background SGLT-2 inhibitors and GLP-1 receptor agonists exhibit metabolic benefits on improving obesity, diabetes, hypertension and hyperlipidemia, but the differences between them remain unclear. We evaluated the comparative efficacy of these two agents on metabolic benefits in adults wit...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-01-01
|
| Col·lecció: | European Journal of Medical Research |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s40001-026-03986-w |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|